Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Aspartate aminotransferase increased
ADR ID BADD_A00352
ADR Hierarchy
13      Investigations
13.03      Hepatobiliary investigations
13.03.01      Liver function analyses
13.03.01.006      Aspartate aminotransferase increased
Description A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen. [CTCAE]
MedDRA Code 10003481
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Aspartate aminotransferase increase | Aspartate aminotransferase increased | AST increased | Glutamic-oxaloacetic transam incr | Glutamic-oxaloacetic transam. increased | Glutamic-oxaloacetic transaminase increased | GOT inc | GOT increased | GOT increased transient | Serum glutamic-oxaloacetic ta inc | Serum glutamic-oxaloacetic ta increased | Serum glutamic-oxaloacetic transaminase increased | SGOT increased | Transaminase glutamic-oxalacetic increased | AST flare up | AST high
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Alpha-mannosidase 2Q16706T68668
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02406Radium ra 223 dichloride--
BADD_D02414Mesalazine0.002124%
BADD_D02424Valaciclovir0.000603%
BADD_D02436Atorvastatin--
BADD_D02438Enoxaparin0.004722%
BADD_D02443Tiotropium--
BADD_D02458Glycine betaine0.097284%
BADD_D02459Dalteparin0.025409%
BADD_D02463Pitavastatin0.002784%
BADD_D02464Fingolimod0.170803%
BADD_D02468Cannabidiol--
BADD_D02470Nintedanib0.002664%
BADD_D02480Alectinib0.000533%
BADD_D02483Ribociclib0.004263%
BADD_D02486Niraparib0.000799%
BADD_D02504Lorlatinib0.000799%
BADD_D02510Rucaparib0.008792%
BADD_D02515Pexidartinib0.001865%
BADD_D02520Baloxavir marboxil0.001447%
The 20th Page    First    Pre   20    Total 20 Pages